Dupilumab efficacy and safety up to 2 years in children aged 6 months to 5 years with atopic dermatitis

被引：0

作者：

Paller, Amy S. ^{[1
,2
]}

Simpson, Eric L. ^{[3
]}

Siegfried, Elaine C. ^{[4
,5
]}

Cork, Michael J. ^{[6
,7
]}

Arkwright, Peter D. ^{[8
]}

Pinter, Andreas ^{[9
]}

Dubost-Brama, Ariane ^{[10
]}

Laws, Elizabeth ^{[11
]}

Chen, Zhen ^{[12
]}

Bansal, Ashish ^{[12
]}

Prescilla, Randy ^{[11
]}

Nguyen, Tien, V ^{[13
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

[2] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA

[3] Oregon Hlth & Sci Univ, Portland, OR USA

[4] St Louis Univ, St Louis, MO USA

[5] Cardinal Glennon Childrens Hosp, St Louis, MO USA

[6] Univ Sheffield, Sheffield Dermatol Res, Sheffield, England

[7] Sheffield Childrens Hosp, Sheffield, England

[8] Univ Manchester, Manchester, England

[9] Univ Hosp Frankfurt Main, Frankfurt, Germany

[10] Sanofi, Chilly Mazarin, France

[11] Sanofi, Cambridge, MA USA

[12] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[13] Regeneron Pharmaceut Inc, Los Angeles, CA USA

来源：

关键词：

atopic dermatitis; pediatric; long-term; safety; dupilumab;

D O I：

10.1093/bjd/ljae266.075

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

701

引用

页码：78 / 79

页数：2